Health Views
Add a commentResearchers at Trinity College Dublin have reported the development of a new drug delivery system which has the potential to treat degenerative diseases of the retina, including retinitis pigmentosa (RP), age-related macular degeneration and diabetic retinopathy.
The research was led by Dr Matthew Campbell and Professor Peter Humphries of TCD’s Smurfit Institute of Genetics and School of Genetics and Microbiology.
The new process has been used in the suppression of new retinal blood vessel growth in mice, a phenomenon called neovascularisation, which is the major sight-threatening symptom associated with age-related macular degeneration in humans.
For more information go to www.maculardegenerationassociation.org
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment